View SAPRP grants by type:

View SAPRP grants by:
Topic
,
Date or Investigator r

 

Treatment Access Grants

Grants listed by date, with most recent appearing first. Click a grant title for detailed information, including a summary and publications.

Reducing or Expanding Substance Use Disorder Treatment Programs: Evaluating Impact from the Health Care Decision-Maker's Perspective, Keith Humphreys, Ph.D.
Increasing Access to Substance Abuse Treatment: Resolving the “Not in My Back Yard” Phenomenon Regarding Substance Abuse Treatment Centers, Susan Boyd, M.D.
Evaluation of Pharmacy-Based Drug Treatment Linkages through the New York State Expanded Syringe Access Demonstration Program (ESAP), Crystal Fuller, Ph.D.
Service Delivery and Use of Evidence-Based Treatment Practice in Adolescent Substance Abuse Treatment Settings, Hannah Knudsen, Ph.D.
Understanding the Impacts of Funding Volatility on Treatment Services, Patricia Ebener,
Improving Treatment for Medicaid Beneficiaries with Co-Occurring Disorders, Robin Clark, Ph.D.
Pharmacists' Knowledge and the Drug Addiction Treatment Act, Tony Tommasello, Ph.D.
Supplement to Implementation and Impact of California's Proposition 36: Implications for the Future, Nell Griffith Forge, Ph.D., M.P.H.
Office-Based Buprenorphine in Washington State, Joseph Merrill, M.D., M.P.H.
Public Financing and Treatment for Dual Disorders: A Case Study, Robin Clark, Ph.D.
Substance Abuse Treatment for Pregnant Women Under Managed Care, Janet Mitchell, Ph.D.
Impact of Managed Care Contracting Arrangements on Access to Substance Abuse Services, Janet Mitchell, Ph.D.
Supplement to: Elimination of Drug and Alcohol Abuse as an Eligibility Category for SSI, Shanthi Kappagoda, M.S.
The Impact of Welfare Reform on Mothers Convicted of a Drug Offense, Carol Boyd, M.S.N., Ph.D., R.N.
Pathways to Substance Abuse Treatment for Adolescents in an HMO: Implications for Policy, Constance Weisner, Dr.P.H., M.S.W.
Increasing Substance Abuse Screening and Referral Rates in an Independent Practice Association Managed Health Care Organization, Neal Dawson, M.D.
Welfare Reform and Substance Abuse Policy Changes: Reducing the Harm to Parents, Heroin Addicts, and Disabled Persons, Richard Speiglman, D.Crim.
Identifying Best Practices among Managed Care Plans that Provide Substance Abuse Treatment Services to Medicaid Recipients with Disabilities, Sara Bachman, Ph.D.
Methadone Maintenance in Primary Care, Joseph Merrill, M.D., M.P.H.
The Impact of Treatment on Demand on Injection Drug Users in the SF Bay Area, Brian Edlin, M.D.
Developing a Foundation for Outcome Based Purchasing of Addictions Treatment, Norman Hoffmann, Ph.D.
Effects of the Elimination of SSI Drug Addiction and Alcoholism Eligibility: Phase 2, Richard Speiglman, D.Crim.
Impact of Terminating DA&A SSI/SSDI Benefits, Paul Goldstein, Ph.D.
An Ethical and Legal Analysis of State-compelled Loss of Liberty as an Intervention to Reduce the Harm of Perinatal Substance Abuse and Addiction, Mary Faith Marshall, Ph.D.
Effects of the Elimination of SSI Drug Addiction and Alcoholism: Phase I, Richard Speiglman, D.Crim.
Perinatal Substance Use Treatment and Related Services in a Managed Care Environment, Mary Haack, Ph.D.
Federal and State Level Policies and Women: Impact on Services for Alcohol, Tobacco, and Other Drugs, Beth Reed, Ph.D.
 
   
 
 
     
   
  About SAPRP  | SAPRP Staff | Questions | P: 336.286.4548 | F: 336.286.4550 

SAPRP . One Leadership Place . Greensboro, NC 27410 . saprp@ccl.org